Barclays
HLTH

Barclays’s Cue Health Inc. Common Stock HLTH Stock Holding History

Barclays’s Portfolio HLTH Stock Details HLTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-55,436
Closed -$101K – 5216
2023
Q1 		$101K Buy
55,436
+26,201
+90% +$56.9K ﹤0.01% 4172
2022
Q4 		$60.5K Buy
29,235
+24,619
+533% +$77.8K ﹤0.01% 4475
2022
Q3 		$14K Sell
4,616
-6,677
-59% -$23.7K ﹤0.01% 4194
2022
Q2 		$36K Buy
11,293
+8,838
+360% +$47.9K ﹤0.01% 4178
2022
Q1 		$17K Buy
+2,455
New +$22.2K ﹤0.01% 4490

Other funds holding HLTH

KI
Koch Industries Wichita, Kansas $853M AUM 37.49% 1-Year Est. Return
OC
Oakmont Corp Los Angeles, California $526M AUM 7.52% 1-Year Est. Return
DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
JPC
Jabodon PT Co Reno, Nevada $1.02B AUM 22.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Barclays's HLTH Position: Q2 2023 in Review

Barclays sold out of Cue Health Inc. Common Stock (HLTH) in Q2 2023, closing a stake of 55,436 shares — an estimated $101K sold.

Barclays first reported a position in HLTH in Q1 2022 and held it in 5 quarters. The position peaked at $101K in Q1 2023. 79 funds tracked by Wall St. Rank hold HLTH as of Q2 2023.

  • Barclays reported no remaining Cue Health Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Barclays sold 55,436 Cue Health Inc. Common Stock shares in Q2 2023, an estimated $101K.
  • Barclays first reported a position in Cue Health Inc. Common Stock in Q1 2022 and held it in 5 quarters.
  • Barclays's Cue Health Inc. Common Stock position peaked at $101K in Q1 2023.
  • 79 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q2 2023.

Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.